KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Enterprise Value (2016 - 2025)

Charles River Laboratories International has reported Enterprise Value over the past 17 years, most recently at -$208.5 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$208.5 million for Q4 2025, down 35.83% from a year ago — trailing twelve months through Dec 2025 was -$208.5 million (down 35.83% YoY), and the annual figure for FY2025 was -$208.5 million, down 35.83%.
  • Enterprise Value for Q4 2025 was -$208.5 million at Charles River Laboratories International, down from -$166.6 million in the prior quarter.
  • Over the last five years, Enterprise Value for CRL hit a ceiling of -$117.2 million in Q3 2023 and a floor of -$437.4 million in Q1 2021.
  • Median Enterprise Value over the past 5 years was -$177.8 million (2022), compared with a mean of -$191.4 million.
  • Biggest five-year swings in Enterprise Value: soared 57.46% in 2022 and later plummeted 69.72% in 2024.
  • Charles River Laboratories International's Enterprise Value stood at -$188.2 million in 2021, then dropped by 1.74% to -$191.5 million in 2022, then decreased by 14.92% to -$220.0 million in 2023, then soared by 30.25% to -$153.5 million in 2024, then plummeted by 35.83% to -$208.5 million in 2025.
  • The last three reported values for Enterprise Value were -$208.5 million (Q4 2025), -$166.6 million (Q3 2025), and -$142.9 million (Q2 2025) per Business Quant data.